• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON SARL GYNECARE TVT OBTURATOR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON SARL GYNECARE TVT OBTURATOR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number 810081L
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Erosion (1750); Pain (1994); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).Total number of events ¿ (b)(4).Gynecare tvt ¿ (b)(4).Gynecare tvt abbrevo ¿ (b)(4).Gynecare tvt exact continence system ¿ (b)(4).Gynecare tvt obturator system ¿ (b)(4).Gynecare tvt retropubic system ¿ (b)(4).Gynecare tvt-aa abdominal ¿ (b)(4).
 
Event Description
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2009 and the mesh was implanted due to uterine prolapse, cystocele, rectocele and stress urinary incontinence.Following the procedure, the patient experienced pain and erosion and underwent revision surgeries.No further information is available.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2016.
 
Manufacturer Narrative
Date sent to the fda: 04/20/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(4) 2016.
 
Manufacturer Narrative
Date sent to the fda: 08/29/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.Supplemental 05 - attachment: [(b)(4) otn supplemental 05.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2016 through (b)(4) 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2016 through (b)(6) 2016 supplemental 06 - attachment: [(b)(6) 2016 otn supplemental 06.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037 reporting period (b)(4) 2016 through (b)(4) 2016.
 
Manufacturer Narrative
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 6/25/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 02/17/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 02/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 10/282019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 04/19/2021.
 
Manufacturer Narrative
Date sent to fda: 06/18/2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE TVT OBTURATOR SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON SARL
puits-godet 20
neuchatel 2000
SZ  2000
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20
neuchatel 2000
SZ   2000
Manufacturer Contact
kenneth clark
route 22 westp o box 151
somerville, NJ 08876
9082183547
MDR Report Key6195521
MDR Text Key63050019
Report Number2210968-2016-34462
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K033568
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 09/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2009
Device Catalogue Number810081L
Device Lot Number3238501
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/18/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/03/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-